PFENEX
Headquartered in San Diego, California, Pfēnex Inc. is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars. The Company's core technology, Pfēnex Expression Technology™, is a cutting edge protein expression platform that utilizes the BSL-1 microorganism Pseudomonas fluorescens. Pfēnex Expression Technology™ combines an extensive toolbox of expression components with a robotically enabled high throughput parallel strain screening technology, delivering unprecedented speed and success in identifying protein production strains expressing high titers of soluble active protein.
PFENEX
Industry:
Biotechnology Health Care Therapeutics
Founded:
2009-12-07
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.pfenex.com
Total Employee:
11+
Status:
Active
Contact:
18583524339
Email Addresses:
[email protected]
Total Funding:
63.4 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 Microsoft Azure DNS GoDaddy DNS COVID-19 CloudFront
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Kodiak Sciences
Kodiak is designing and developing novel therapies for the treatment of retinal disease.
Nurix Therapeutics
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Signet Healthcare Partners
Signet Healthcare Partners investment in Series A - Pfenex
The Dow Chemical Company
The Dow Chemical Company investment in Series A - Pfenex
Newest Events participated
Participated in Viral Safety 2017
on 2017-04-25 as exhibitor
Official Site Inspections
http://www.pfenex.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pfenex"
Pfenex Expression Technology - Primrose Bio, Inc.
The Pfenex Expression Technology® (Pfenex) is the most comprehensive prokaryotic expression platform under one roof: powered by Pseudomonas fluorescens.See details»
Pfenex - Profiles & Contacts - Crunchbase
Pfenex develops biosimilar therapeutics and novel vaccines for the treatment and prevention of critical human health issues.See details»
Leader in Analytical Chemistry Solutions | Phenomenex
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.See details»
Pfenex - News & Analysis - Crunchbase
Pfenex develops biosimilar therapeutics and novel vaccines for the treatment and prevention of critical human health issues.See details»
Organization | Pfenex, Inc
Pfenex, Inc Report issue For profit Phase 1 Phase 2 Phase 3 Founded: San Diego CA United States (2009) Status: Acquired by Ligand Pharmaceuticals (2020)See details»
Pfenex - Financial Details - Crunchbase
Pfenex develops biosimilar therapeutics and novel vaccines for the treatment and prevention of critical human health issues.See details»
About Pfenex Inc (PFNX) - Investing.com
This page offers an in-depth profile of Pfenex Inc, including a general overview of the company's business and key management.See details»
Pfenex Inc. (PFNX) 10K Annual Reports & 10Q SEC Filings
Mar 11, 2020 Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Pfenex Inc. (PFNX) using our online tools.See details»
Pfenex - Contacts, Employees, Board Members, Advisors & Alumni
Pfenex develops biosimilar therapeutics and novel vaccines for the treatment and prevention of critical human health issues.See details»
Pfenex - Products, Competitors, Financials, Employees, …
Pfenex is a clinical-stage biotechnology company that is developing complex therapeutic proteins. Using the patented Pfenex Expression Technology platform, the company has created an …See details»
Pfenex - VentureRadar
Pfenex Inc. existed as a privately held biotechnology company from 2009 until our initial public offering in 2015. When Pfenex spun out of Dow, we were assigned the entire intellectual …See details»
Pfenex Inc.: Governance, Directors and Executives & Committees ...
Find the composition of the Board of Directors of Pfenex Inc. (Nyse Stock Exchange), the gender parity as well as the age distribution of the insiders.See details»
Pfenex Inc Careers and Employment | Indeed.com
Mar 7, 2020 Find out what works well at Pfenex Inc from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular …See details»
Pfenex Inc - AnnualReports.com
Pfenex Inc., a clinical-stage biotechnology company, develops biosimilar therapeutics. Its lead product candidate is PF582, a biosimilar candidate to Lucentis that is in Phase Ib/IIa trials in …See details»
Organizational Culture for Pfenex Inc - 247caseanalysis.com
Introduction Pfenex Inc is a large scnale company with many employees; the company treats its employees as an asset. The aim of the Pfenex Inc organisational culture is to create a positive …See details»
paul wagner - CFO - Pfenex | LinkedIn
CFO at Pfenex · Experience: Pfenex · Location: Los Angeles · 1 connection on LinkedIn. View paul wagner’s profile on LinkedIn, a professional community of 1 billion members.See details»
Primrose Bio Showcases Pfenex Platform and Pfast™ at PEGS US …
May 17, 2025 Primrose Bio highlighted Pfastâ„¢ and Pfenex Expression Technology® at PEGS Boston 2025, advancing complex protein development and biotherapeutic screening.See details»
About Us - Primrose Bio, Inc.
About us Expanding Global Health Through Innovative Biologics Founded in 2023 following the merger of Pelican Technology Holdings (formerly Pfenex) and Primordial Genetics, Primrose …See details»
The Dow Chemical Company Announces Formation of Pfenex Inc …
Dec 7, 2009 The new company, headquartered in San Diego, California, is based on human health applications of a Dow-developed technology called Pfenex Expression Technologyâ„¢, a …See details»
Pfenex: Bacterial System Overcomes Protein Challenges, Inhouse …
Jun 22, 2018 Pfenex span out from Dow in 2009, and while clearly expression rates are not all in double-digit grams per liter for its therapeutic products, the system has many other benefits, …See details»